The American Society for Clinical Oncology (ASCO) annual meeting took place in a virtual format on 29–31 May 2020. Over the three days, exciting work was presented from across the globe, to continue to advance the oncology field and patient outcomes.
Was such an honor to deliver the @ASCO Opening Address. I shared some thoughts about my talk and 5 key messages while receiving my monthly infusion. It felt like a fitting time to share about being a patient-physician-researcher-caregiver-advocate #ASCO20#ChasingMyCurepic.twitter.com/v2srwY0GNB
Preliminary but fascinating data on CART and TCR-T activity on solid tumors. An HPV E7-targeting TCR-T demonstrated sustained clinical in half of the 12 patients treated. Solid tumors are the next frontier for cellular therapy #ASCO20pic.twitter.com/Dc0osx3WSW